229 related articles for article (PubMed ID: 19874893)
1. A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium.
Ferrucci M; Spalloni A; Bartalucci A; Cantafora E; Fulceri F; Nutini M; Longone P; Paparelli A; Fornai F
Neurobiol Dis; 2010 Feb; 37(2):370-83. PubMed ID: 19874893
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS.
Kadoyama K; Funakoshi H; Ohya W; Nakamura T
Neurosci Res; 2007 Dec; 59(4):446-56. PubMed ID: 17935811
[TBL] [Abstract][Full Text] [Related]
3. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
[TBL] [Abstract][Full Text] [Related]
4. Differential vulnerability of cranial motoneurons in mouse models with motor neuron degeneration.
Haenggeli C; Kato AC
Neurosci Lett; 2002 Dec; 335(1):39-43. PubMed ID: 12457737
[TBL] [Abstract][Full Text] [Related]
5. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.
Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP
Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986
[TBL] [Abstract][Full Text] [Related]
6. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin gene-related peptide expression levels predict motor neuron vulnerability in the superoxide dismutase 1-G93A mouse model of amyotrophic lateral sclerosis.
Ringer C; Weihe E; Schütz B
Neurobiol Dis; 2012 Jan; 45(1):547-54. PubMed ID: 21964254
[TBL] [Abstract][Full Text] [Related]
8. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
9. Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice.
Turner BJ; Rembach A; Spark R; Lopes EC; Cheema SS
J Neurosci Res; 2003 Nov; 74(4):605-13. PubMed ID: 14598305
[TBL] [Abstract][Full Text] [Related]
10. Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study.
Marcuzzo S; Zucca I; Mastropietro A; de Rosbo NK; Cavalcante P; Tartari S; Bonanno S; Preite L; Mantegazza R; Bernasconi P
Exp Neurol; 2011 Sep; 231(1):30-7. PubMed ID: 21620832
[TBL] [Abstract][Full Text] [Related]
11. Serotonergic mechanisms in amyotrophic lateral sclerosis.
Sandyk R
Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
[TBL] [Abstract][Full Text] [Related]
12. Brainstem motor nuclei respond differentially to degenerative disease in the mutant mouse wobbler.
Clowry GJ; McHanwell S
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):148-60. PubMed ID: 15043712
[TBL] [Abstract][Full Text] [Related]
13. [On brain stem disorders in amyotrophic lateral sclerosis (electromyographic analysis)].
Shaposhnikov EA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(5):691-7. PubMed ID: 5698409
[No Abstract] [Full Text] [Related]
14. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice.
Tanaka K; Okada Y; Kanno T; Otomo A; Yanagisawa Y; Shouguchi-Miyata J; Suga E; Kohiki E; Onoe K; Osuga H; Aoki M; Hadano S; Itoyama Y; Ikeda JE
Exp Neurol; 2008 Jun; 211(2):378-86. PubMed ID: 18423451
[TBL] [Abstract][Full Text] [Related]
15. Differential vulnerability of oculomotor, facial, and hypoglossal nuclei in G86R superoxide dismutase transgenic mice.
Nimchinsky EA; Young WG; Yeung G; Shah RA; Gordon JW; Bloom FE; Morrison JH; Hof PR
J Comp Neurol; 2000 Jan; 416(1):112-25. PubMed ID: 10578106
[TBL] [Abstract][Full Text] [Related]
16. Vacuolization correlates with spin-spin relaxation time in motor brainstem nuclei and behavioural tests in the transgenic G93A-SOD1 mouse model of ALS.
Bucher S; Braunstein KE; Niessen HG; Kaulisch T; Neumaier M; Boeckers TM; Stiller D; Ludolph AC
Eur J Neurosci; 2007 Oct; 26(7):1895-901. PubMed ID: 17868365
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging of neurodegeneration by a novel cross-disease biomarker.
Shirvan A; Reshef A; Yogev-Falach M; Ziv I
Exp Neurol; 2009 Sep; 219(1):274-83. PubMed ID: 19500576
[TBL] [Abstract][Full Text] [Related]
18. Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis.
Petri S; Kiaei M; Kipiani K; Chen J; Calingasan NY; Crow JP; Beal MF
Neurobiol Dis; 2006 Apr; 22(1):40-9. PubMed ID: 16289867
[TBL] [Abstract][Full Text] [Related]
19. Disease-related regressive alterations of forebrain cholinergic system in SOD1 mutant transgenic mice.
Crochemore C; Peña-Altamira E; Virgili M; Monti B; Contestabile A
Neurochem Int; 2005 Apr; 46(5):357-68. PubMed ID: 15737434
[TBL] [Abstract][Full Text] [Related]
20. Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS.
Comley L; Allodi I; Nichterwitz S; Nizzardo M; Simone C; Corti S; Hedlund E
Neuroscience; 2015 Apr; 291():216-29. PubMed ID: 25697826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
